Hepo Biology Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Investors
  • 4

Hepo Biology General Information

Description

Developer of 3D organ models and organ-on-a-chip technology intended for innovative drug development. The company offers preclinical safety, effectiveness and metabolic evaluation services using 3d micro-tissue platform technology, providing pharmaceutical enterprises with drug research and development support.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 214
  • Number. 2388 Xiupu Road, Pudong New Area
  • Shanghai, 201315
  • China
+86 186
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • Room 214
  • Number. 2388 Xiupu Road, Pudong New Area
  • Shanghai, 201315
  • China
+86 186

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hepo Biology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 28-Aug-2026 Completed Generating Revenue
3. Early Stage VC 10-Apr-2024 Completed Generating Revenue
2. Grant 06-Nov-2023 Completed Generating Revenue
1. Seed Round 30-Aug-2023 Completed Startup
To view Hepo Biology’s complete valuation and funding history, request access »

Hepo Biology Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
TriApex Corporation Minority
Shanghai Genesis International Equity Investment Management VC-Backed Company Minority
Yongkan Investment Venture Capital Minority
Guangzhou Industrial Investment Holding Group Government Minority
To view Hepo Biology’s complete investors history, request access »

Hepo Biology FAQs

  • When was Hepo Biology founded?

    Hepo Biology was founded in 2022.

  • Where is Hepo Biology headquartered?

    Hepo Biology is headquartered in Shanghai, China.

  • What industry is Hepo Biology in?

    Hepo Biology’s primary industry is Biotechnology.

  • Is Hepo Biology a private or public company?

    Hepo Biology is a Private company.

  • What is Hepo Biology’s current revenue?

    The current revenue for Hepo Biology is .

  • Who are Hepo Biology’s investors?

    TriApex, Shanghai Genesis International Equity Investment Management, Yongkan Investment, and Guangzhou Industrial Investment Holding Group have invested in Hepo Biology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process